Aikaterini Lalatsa - Concepedia

Author

Aikaterini Lalatsa

University of Portsmouth ORCID

Also Known As

A. Lalatsa, Aikaterina Lalatsa, Aikaterini Lalatsa, Katerina Lalatsa, Lalatsa, A, Lalatsa, A., SchÃ¤tzlein, Andreas G

100

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

University of Portsmouth Universidad Complutense de Madrid Universidad Cardenal Herrera CEU University of Strathclyde University College London

About

Aikaterini Lalatsa is an author at University of Portsmouth specializing in engineering, biomedical engineering, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	13	15	692
2	Biomedical Engineering	11	13	618
3	Medicine	10	11	495
4	Biomolecular Engineering	3	3	112
5	Education	1	1	223

Aikaterini Lalatsa

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Technology‐enhanced learning in higher education: How to enhance student engagement through blended learning Dolores R. Serrano, María Auxiliadora Dea‐Ayuela, Elena González‐Burgos, European Journal of Education E-learningTechnology‐enhanced LearningEducationOnline LearningTechnology Integration	2019	223
Oral Particle Uptake and Organ Targeting Drives the Activity of Amphotericin B Nanoparticles Dolores R. Serrano, Aikaterini Lalatsa, María Auxiliadora Dea‐Ayuela, Molecular Pharmaceutics NanoparticlesGastric DegradationEngineeringBiomedical EngineeringProtein Nanoparticles	2015	109
Delivery of Peptides to the Blood and Brain after Oral Uptake of Quaternary Ammonium Palmitoyl Glycol Chitosan Nanoparticles Aikaterini Lalatsa, Natalie Garrett, Teresa Ferrarelli, Molecular Pharmaceutics NanoparticlesNanomedicineEngineeringTherapeutic PeptidesGcpq Nanoparticles	2012	91
3D printed spherical mini-tablets: Geometry versus composition effects in controlling dissolution from personalised solid dosage forms Sejad Ayyoubi, José R. Cerda, Raquel Fernández-García, International Journal of Pharmaceutics Materials ScienceSolid Dosage FormsEngineeringMicro-encapsulationPharmaceutical Technology	2021	84
Nanoparticulate peptide delivery exclusively to the brain produces tolerance free analgesia Lisa Godfrey, Antonio Iannitelli, Natalie Garrett, Journal of Controlled Release	2017	77
Personalised 3D Printed Medicines: Optimising Material Properties for Successful Passive Diffusion Loading of Filaments for Fused Deposition Modelling of Solid Dosage Forms José R. Cerda, Talaya Arifi, Sejad Ayyoubi, Pharmaceutics	2020	74
A Prodrug Nanoparticle Approach for the Oral Delivery of a Hydrophilic Peptide, Leucine<sup>5</sup>-enkephalin, to the Brain Aikaterini Lalatsa, Vivian Lee, John P. Malkinson, Molecular Pharmaceutics NanoparticlesEngineeringBrain DiseasePeptide SciencePeptide Therapeutics	2012	73
Orally Bioavailable and Effective Buparvaquone Lipid-Based Nanomedicines for Visceral Leishmaniasis Lindsay Smith, Dolores R. Serrano, Marion Mauger, Molecular Pharmaceutics	2018	56
Designing Fast-Dissolving Orodispersible Films of Amphotericin B for Oropharyngeal Candidiasis Dolores R. Serrano, Raquel Fernández-García, Marta Melé, Pharmaceutics	2019	51
Label‐free imaging of polymeric nanomedicines using coherent anti‐stokes Raman scattering microscopy Natalie Garrett, Aikaterini Lalatsa, David J. Begley, Journal of Raman Spectroscopy NanoparticlesNanotherapeuticsEngineeringMicroscopySurface-enhanced Raman Scattering	2012	49

Page 1